ValuEngine downgraded shares of Avalon Globocare C (OTCMKTS:AVCO) from a buy rating to a hold rating in a research note released on Friday.
AVCO opened at $2.50 on Friday. Avalon Globocare C has a fifty-two week low of $0.51 and a fifty-two week high of $4.60.
COPYRIGHT VIOLATION NOTICE: “ValuEngine Downgrades Avalon Globocare C (AVCO) to Hold” was first published by Ticker Report and is owned by of Ticker Report. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3342121/valuengine-downgrades-avalon-globocare-c-avco-to-hold.html.
Avalon GloboCare Corp. provides healthcare services in the United States and the People?s Republic of China. The company operates through three platforms, such as Avalon Cell, Avalon Telemedicine, and Avalon Rehab that cover the areas of regenerative medicine, cell-based immunotherapy, exosome technology, and telemedicine with medical second opinion/referral services, as well as fertility and rehabilitation medicine.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Avalon Globocare C Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon Globocare C and related companies with MarketBeat.com's FREE daily email newsletter.